| Literature DB >> 24989069 |
Caroline S Kampshoff, Femke Jansen, Willem van Mechelen, Anne M May, Johannes Brug, Mai J M Chinapaw, Laurien M Buffart1.
Abstract
For an exercise intervention to be successful, it is important that cancer survivors adhere to the prescribed program. To be able to improve adherence and to preserve achieved beneficial effects, insights into the relevant and modifiable determinants is important. Therefore, we aimed to systematically review determinants of exercise adherence and maintenance in cancer survivors using a socio-ecological approach.Studies were identified in PubMed, Embase, PsycINFO and SPORTDiscus up to July 2013. We included full-text articles that: 1) were conducted among adult cancer survivors; 2) quantitatively assessed factors associated with intervention adherence and maintenance, and 3) were published in English. The methodological quality of the selected studies was examined. A best evidence synthesis was applied. Eighteen studies were included. Median methodological quality was 53% and ranged from 21-78% of maximum score. Twelve studies focused on determinants of exercise adherence and evaluated 71 potential determinants: 29 demographic and clinical, 27 psychological, ten physical, four social factors, and one environmental factor. Six studies focused on determinants of exercise maintenance after completion of an intervention, and investigated 63 factors: 22 demographic and clinical, 28 psychosocial, nine physical, three social and one environmental factor. We found moderate evidence for a positive association between exercise history and exercise adherence. Inconsistent findings were found for age, gender and education as well as for psychological factors such as stage of change, perceived behavioral control, self-efficacy, extraversion, attitude, intention, fatigue, and quality of life, and physical factors including cardiovascular fitness, body mass index, and baseline physical activity.Exercise history is positively associated with exercise adherence. Future trials should further study the influence of social and environmental determinants on exercise adherence and maintenance in addition to demographic, psychological and physical determinants.Entities:
Mesh:
Year: 2014 PMID: 24989069 PMCID: PMC4096543 DOI: 10.1186/1479-5868-11-80
Source DB: PubMed Journal: Int J Behav Nutr Phys Act ISSN: 1479-5868 Impact factor: 6.457
Methodological quality assessment tool and quality score of the included studies (n = 18)
| | | | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| | | | | | | | | | | | | | | | | |||||
| [ | [ | [ | [ | [ | [ | [ | [ | [ | [ | [ | [ | [ | [ | [ | [ | [ | [ | |||
| Topic | | | | | | | | | | | | | | | | | | | | |
| A. Description of cancer type, stage and treatment | I | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 100 |
| B. Description of inclusion and exclusion criteria | I | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 100 |
| C. Positive if the participation rate at baseline was at least 80%, or if the non-response was not selectivea | V/P | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | ? | 0 | 0 | 1 | 0 | 0 | 16 |
| | | | | | | | | | | | | | | | | | | | | |
| D. Number of patients included in the analysis ≥100 | V | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 26 |
| E. Positive if the response at first follow-up was at least 80%, or if the non-response at first follow-up was not selectiveb | V/P | 0 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 80 |
| | | | | | | | | | | | | | | | | | | | | |
| F. Positive if determinants of adherence were measured with a reliable toolc | V/P | 0.5 | 0.7 | 0.5 | 0.6 | 0.6 | 0.8 | 0.6 | 0.8 | 0.7 | 0.7 | 0.5 | 0.8 | 0.7 | 0.8 | 0.7 | 0.4 | 0.5 | 0.7 | 63 |
| G. Positive if determinants of adherence were measured with a valid toold | V/P | 0.2 | 0.5 | 0.5 | 0.2 | 0.6 | 0.5 | 0.6 | 0.8 | 0.6 | 0.6 | 0.2 | 0.6 | 0.7 | 0.6 | 0.4 | 0 | 0 | 0 | 40 |
| | | | | | | | | | | | | | | | | | | | | |
| H. Adherence was measured by an objective toole | V/P | 1 | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 37 |
| | | | | | | | | | | | | | | | | | | | | |
| I. Multivariate analysis techniques was used. | V/P | 0 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 38 |
| J. Results were presented as point estimates (mean differences/Beta’s/correlation coefficients) and measures of variability (SD, standard error or CI) | I | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 37 |
| K. Positive if number of samples is at least 10 times the number of independent variables | V/P | 0 | 1 | 1 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 42 |
1, study provided information on the quality item and met the criterion; 0, study provided information on the quality item but did not meet the criterion; ?,study provided no or insufficient information on the quality item.
I: informativeness; V: validity/P: precision. aattrition analyses were performed and results showed no significant differences between baseline study sample and population of eligible subjects; battrition analyses were performed and results showed no significant differences between dropouts and follow‒up participants; cassociated factors showed internal consistency of Cronbach's alpha ≥0.70 or test‒retest correlations of ≥0.80 or κ/ICC ≥0.70. For clinical factors a standardized protocol was followed by trained researchers; dassociated factors showed correlations of ≥0.80 or κ/ICC ≥0.70 with similar constructs. For physical variables (i.e., past physical activity and past sedentary behavior) an objective measurement instrument (i.e., accelerometer/pedometer) was used. For clinical variables a standardized protocol was followed by trained researchers; eFor walking interventions: adherence or maintenance was measured by accelerometer or pedometer read out by the researcher. For supervised exercise : the trainer reported presence of the participant; fthe number of items scored positively on the validity/precision (V/P) criteria divided by the total number of validity/precision criteria (i.e. 8).
Figure 1Flowchart of conducted literature search and study inclusion.
Characteristics of the included studies (n = 18)
| | | | | | | |
| Peddle, 2009 [ | Lung cancer | n = 19; 64 ± 10y; 68% female | Single-group trial | AET 5 times a week for the duration of surgical wait time (range 4–13 weeks) | Percentage of the prescribed number of sessions attended | 73 ± 35% |
| | | | | | ||
| Courneya, 2008 [ | Breast cancer | n = 160; 49y; 100% female | Three-armed RCT | 1) Supervised AET or 2) RET, 3 times a week for the duration of CT (ranging from 12 to 24 weeks) | Percentage of the expected number of sessions attended | Group 1: 72.0 ± 30.1%; Group 2: 68.2 ± 28.4% |
| Klepin, 2011 [ | Acute myelogenous leukemia | n = 24; 65.1 ± 7.8y; 62.5% female | Single-group trial | Supervised AET and strength training 3 times a week for 4 weeks | Number of exercise sessions completed | 2.7 ± 2.4 |
| Shang, 2012 [ | Mixed (34% breast cancer) | N = 68; 59.8 ± 10.8y; 39.7% female | Two-armed RCT | Home-based walking intervention 5 times a week for the duration of RT/CT (ranging from 5 to 35 weeks) | Percentage of patients meeting the personalized exercise prescription > 2/3 of the study period | 67.7% |
| Swenson, 2010 [ | Breast cancer | n = 29; 46.9y (range: 40–54); 100% female | Two-armed RCT | Tools and advise to perform minimal 10,000 steps per day (PA assessed over 12 months) | Percentage of patients meeting the exercise prescription of 10,000 steps per day | 74% |
| | | | | | ||
| Courneya, 2004 [ | Colorectal cancer | n = 62; 59.9 ± 10.7y; 45.2% female | Two-armed RCT | Home-based AET 3–5 times a week for 16 weeks | Average min/week of moderate-strenuous AET performed | 91.5 ± 148.4 min/week |
| Courneya, 2004 [ | Prostate cancer | n = 82; 68.2 ± 7.9y; 0% female | Two-armed RCT | RET at fitness center 3 times a week for 12 weeks | Number of observed exercise session attended | 28.2 ± 7.1 |
| Latka, 2009 [ | Breast cancer | n = 37; 56.5 ± 9.5y; 100% female | Two-armed RCT | Supervised AET 3 times a week and home-based AET 2 times a week for 6 months | Average min/week of moderate-intensity AET performed (prescribed 150 min.) | 122.8 ± 52.4 min/week |
| McGuire, 2011 [ | Breast cancer | n = 120; 58.7y, 100% female | Two-armed RCT | Home-based strength training for 8 months and strength training in a fitness center for the following 16 months, both 2 times a week | Percentage of the prescribed number of sessions performed | 62% |
| Pinto, 2009 [ | Breast cancer | n = 43; 53.4 ± 9.1; 100% female | Two-armed RCT | Home-based walking intervention 2–5 days a week for 12 weeks | Percentage of patients meeting the exercise prescription | 54-91% |
| | | | | | ||
| Courneya, 2002 [ | Mixed (41% breast cancer) | n = 51; 52.5 ± 10.2y; 84.4% female | Two-armed RCT | Home-based AET 3–5 times per week for 10 weeks | Average min/week of moderate-strenuous AET performed | 141.1 ± 129.2 min/week |
| Courneya, 2010 [ | Lymphoma | n = 60; 52.8y (range: 18–77); 38.3% female | Two-armed RCT | Supervised AET 3 times a week for 12 weeks | Percentage of the expected number of sessions attended | 78 ± 30% |
| | | | | | | |
| Courneya, 2004 [ | Mixed (40% breast cancer) | n = 30; 54.9 ± 8.0y; 77% female | Two-armed RCT | Home-based AET 3–5 times per week for 10 weeks | Average min/week of moderate-strenuous exercise | 146.3 ± 143.5 min/week |
| Courneya, 2009 [ | Breast cancer | n = 201; 49y; 100% female | Three-armed RCT | 1) Supervised AET; 2) RET 3 times a week for the duration of CT (ranging from 12 to 24 weeks) or 3) a delayed 1 month supervised program for usual care patients | Meeting AET and/or RET guidelines | Neither: 42.3%; either: 36.8%; both: 20.9% |
| Courneya, 2011 [ | Lymphoma | n = 110; 44 pt <55y and 66 pt ≥55y; 43.6% female | Two-armed RCT | 1) Supervised AET 3 times a week for 12 weeks or 2) a delayed 1 month supervised program for usual care | Percentage of patients meeting ACSM guideline | 55.5% |
| Loprinzi, 2012 [ | Breast cancer | n = 69; 70.6 ± 1.2y; 100% female | Three-armed RCT | 1) Supervised AET; 2) supervised RET or 3) supervised stretching and relaxation exercise 3 times a week for 12 months | Activity status based on TTM stages | Sufficiently active: 57%; Insufficiently active: 43% |
| Rogers, 2011 [ | Breast cancer | n = 36; 53 ± 9y; 100% female | Two-armed RCT | 1) 12 individual supervised exercise sessions, 6 discussion group sessions and 3 individual face-to-face counseling sessions over a 3 month period or 2) information on PA after a cancer diagnosis | Daily minutes of activity of moderate-strenuous activity | Group 1: 174.9 min/day; Group 2: 92 min/day |
| Vallance, 2010 [ | Breast cancer | n = 266; 57y (range 36–90); 100% female | Four-armed RCT | Exercise recommendation and 1) nothing, 2) exercise for health book, 3) pedometer or 4)exercise for health book and pedometer | Percentage of patients meeting ACSM guideline | 49.2% |
ACSM = American College of Sports Medicine; AET = aerobic exercise training; CT = chemotherapy; PA = physical activity; RET = resistance exercise training; RT = radiotherapy; TTM = Transtheoretical Model.
Determinants of exercise adherence
| | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| | | | | | | | | | | | | | |
| Age | 12 | 1 [ | 1 [ | 10 [ | C | 4 | | | 4 [ | 5 | | 1 [ | 4 [ |
| Being married | 10 | 1 [ | 1 [ | 8 [ | C | 3 | | 1 [ | 2 [ | 5 | 1 [ | | 4 [ |
| Education | 9 | | | 9 [ | C | 3 | | | 3 [ | 4 | | | 4 [ |
| Employment | 8 | | 1 [ | 7 [ | C | 3 | | | 3 [ | 3 | | 1 [ | 2 [ |
| Gender | 6 | 2 [ | | 4 [ | C | 2 | | | 2 [ | 1 | | | 1 [ |
| Income | 5 | | | 5 [ | C | 1 | | | 1 [ | 2 | | | 2 [ |
| Smoking | 4 | | 1 [ | 3 [ | C | 1 | | | 1 [ | 1 | | | 1 [ |
| Race | 2 | | | 2 [ | C | 2 | | | 2 [ | 0 | | | |
| Disease stage | 10 | 1 [ | | 9 [ | C | 3 | 1 [ | | 2 [ | 5 | | | 5 [ |
| Time since diagnosis/treatment | 7 | | | 7 [ | C | 0 | | | | 5 | | | 5 [ |
| Type of treatment | 5 | 2 [ | | 3 [ | C | 1 | | | 1 [ | 3 | 1 [ | | 2 [ |
| Tumor localization | 4 | | | 4 [ | C | 1 | | | 1 [ | 1 | | | 1 [ |
| Type of surgery | 4 | | | 4 [ | C | 2 | | | 2 [ | 2 | | | 2 [ |
| Radiotherapy | 4 | | | 4 [ | C | 1 | | | 1 [ | 2 | | | 2 [ |
| Chemotherapy | 3 | | | 3 [ | C | 0 | | | | 1 | | | 1 [ |
| Comorbidity | 3 | | | 3 [ | C | 1 | | | 1 [ | 1 | | | 1 [ |
| Chemotherapy cycle | 2 | | | 2 [ | C | 1 | | | 1 [ | 0 | | | |
| Type of chemotherapy | 2 | | | 2 [ | C | 1 | | | 1 [ | 0 | | | |
| Surgery | 2 | | | 2 [ | C | 0 | | | | 1 | | | 1 [ |
| | | | | | | | | | | | | | |
| Attitude | 6 | | | 6 [ | C | 1 | | | 1 [ | 2 | | | 2 [ |
| Intention | 6 | 1 [ | | 5 [ | C | 1 | | | 1 [ | 2 | 1 [ | | 1 [ |
| Perceived behavioral control | 6 | 3 [ | | 3 [ | C | 1 | | | 1 [ | 2 | 1 [ | | 1 [ |
| Social norms | 6 | | | 6 [ | C | 1 | | | 1 [ | 2 | | | 2 [ |
| Quality of life | 6 | | | 6 [ | C | 3 | | | 3 [ | 2 | | | 2 [ |
| Stage of change | 5 | 3 [ | | 2 [ | C | 0 | | | | 5 | 3 [ | | 2 [ |
| Fatigue | 5 | | 1 [ | 4 [ | C | 3 | | 1 [ | 2 [ | 1 | | | 1 [ |
| Depression | 4 | | 1 [ | 3 [ | C | 2 | | 1 [ | 1 [ | 1 | | | 1 [ |
| Self-efficacy | 3 | 1 [ | | 2 [ | C | 0 | | | | 1 | 1 [ | | |
| Anxiety | 3 | | | 3 [ | C | 1 | | | 1 [ | 1 | | | 1 [ |
| Extraversion | 2 | 1 [ | | 1 [ | C | 0 | | | | 1 | | | 1 [ |
| Distress | 2 | | | 2 [ | C | 2 | | | 2 [ | 0 | | | |
| Neuroticism | 2 | | | 2 [ | C | 0 | | | | 1 | | | 1 [ |
| Openness | 2 | | | 2 [ | C | 0 | | | | 1 | | | 1 [ |
| Agreeable | 2 | | | 2 [ | C | 0 | | | | 1 | | | 1 [ |
| Conscientiousness | 2 | | | 2 [ | C | 0 | | | | 1 | | | 1 [ |
| Self-esteem | 2 | | | 2 [ | C | 1 | | | 1 [ | 0 | | | |
| Happiness | 2 | | | 2 [ | C | 0 | | | | 1 | | | 1 [ |
| | | | | | | | | | | | | | |
| Exercise history | 3 | 3 [ | | | B | 1 | 1 [ | | | 1 | 1 [ | | |
| Body mass index | 10 | | 2 [ | 8 [ | C | 4 | | | 4 [ | 4 | | 1 [ | 3 [ |
| PA at baseline | 7 | | | 7 [ | C | 3 | | | 3 [ | 3 | | | 3 [ |
| Body composition | 6 | | | 6 [ | C | 2 | | | 2 [ | 2 | | | 2 [ |
| Cardiovascular fitness | 5 | 2 [ | | 3 [ | C | 2 | 2 [ | | | 1 | | | 1 [ |
| Physical functioning | 4 | 1 [ | | 3 [ | C | 3 | 1 [ | | 2 [ | 0 | | | |
| Muscle strength | 3 | | | 3 [ | C | 2 | | | 2 [ | 1 | | | 1 [ |
| Flexibility | 2 | | | 2 [ | C | 0 | | | | 1 | | | 1 [ |
| | | | | | | | | | | | | | |
| Fitness center | 2 | 1 [ | 1 [ | C | 1 | 1 [ | 1 | 1 [ | |||||
N+, number of studies showing a positive association; N-, number of studies showing a negative association; N0, number of studies showing no association; LoE, Level of Evidence: A. strong evidence; B. moderate evidence; C. insufficient evidence.
PA: physical activity.
Determinants of exercise adherence or maintenance examined in one single study (insufficient evidence)
| Children at home | A [ | Barriers | M [ | Exercise frequency | M [ | Having exercise partner | M [ | Fitness center | M [ |
| Drinking | A [ | Behavioral beliefs | A [ | Exercise limitations | M [ | Having exercise role model | M [ | | |
| Gender | M [ | Control beliefs | A [ | Exertion during PA | A [ | Providing feedback | A [ | | |
| Rural versus urban | A [ | Controllability | M [ | General health | A [ | Promoting knowledge | A [ | | |
| ADT therapy | A [ | Decision balance | A [ | Physical functioning | M [ | Promoting self-efficacy | A [ | | |
| Chemotherapy | M [ | Expectations | M [ | | | Support by friend/family | M [ | | |
| Chemotherapy day | A [ | Expected success | M [ | | | Support by health professional | A [ | | |
| Hormone treatment | A [ | Happiness | M [ | | | | | | |
| Lymphoma symptoms | A [ | Locus | M [ | | | | | | |
| Premenopausal | M [ | Mood disturbance | A [ | | | | | | |
| Radiotherapy | M [ | Negative affect | M [ | | | | | | |
| Relapse disease | A [ | Normative beliefs | A [ | | | | | | |
| Chemotherapy response | M [ | PA enjoyment | M [ | | | | | | |
| Serological parameter | A [ | PA fear | M [ | | | | | | |
| Time since diagnosis | M [ | PA preference | M [ | | | | | | |
| Treatment status | M [ | PA pros/cons | M [ | | | | | | |
| Treatment regime | M [ | Perceived stress | A [ | | | | | | |
| Type of biopsy | A [ | Perceived success | M [ | | | | | | |
| Type of surgery | M [ | Personal control | M [ | | | | | | |
| | | Planning | M [ | | | | | | |
| | | Positive affect | M [ | | | | | | |
| | | Self esteem | M [ | | | | | | |
| | | Stability | M [ | | | | | | |
| | | Symptoms | A [ | | | | | | |
| | | Sleep disturbance | A [ | | | | | | |
| | | Stage of change | M [ | | | | | | |
| View on PA amount | A [ | ||||||||
A = determinants of exercise adherence; M = determinants of exercise maintenance.
ADT = Androgen Deprivation Therapy; PA = physical activity.
Determinants of exercise maintenance
| | | | | | |
| Age | 3 | | 2 [ | 1 [ | C |
| Education | 3 | 1 [ | | 2 [ | C |
| Being married | 3 | | | 3 [ | C |
| Income | 3 | | | 3 [ | C |
| Employment | 3 | | | 3 [ | C |
| Smoking | 2 | | | 2 [ | C |
| Disease stage | 3 | | | 3 [ | C |
| Chemotherapy cycle | 2 | | | 2 [ | C |
| Type of chemotherapy | 2 | | | 2 [ | C |
| | | | | | |
| Self-efficacy | 4 | 2 [ | | 2 [ | C |
| Instrumental attitude | 3 | 2 [ | | 1 [ | C |
| Affective attitude | 3 | 1 [ | | 2 [ | C |
| Fatigue | 3 | | 2 [ | 1 [ | C |
| Quality of life | 3 | 1 [ | | 2 [ | C |
| Intention | 3 | 2 [ | | 1 [ | C |
| Perceived behavioral control | 2 | | | 2 [ | C |
| Social norms | 3 | | | 3 [ | C |
| Anxiety | 2 | | | 2 [ | C |
| Depression | 2 | | | 2 [ | C |
| | | | | | |
| PA intervention adherence | 4 | 2 [ | | 2 [ | C |
| Body mass index | 4 | | 2 [ | 2 [ | C |
| PA at baseline | 3 | 2 [ | | 1 [ | C |
| Body composition | 2 | | | 2 [ | C |
| Cardiovascular fitness | 2 | 1 [ | 1 [ | C |
N+, number of studies showing a positive association; N-, number of studies showing a negative association; N0, number of studies showing no association.
LoE, Level of Evidence: A. strong evidence; B. moderate evidence; C. insufficient evidence.
PA = physical activity.